Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from SKAN Group AG ( (CH:SKAN) ) is now available.
SKAN Group AG has acquired a majority stake in Metronik d.o.o., a leading provider of software solutions for production digitization in the life sciences industry. This acquisition enhances SKAN’s capabilities by integrating Metronik’s modular software platform, which supports the complete digitization of pharmaceutical production processes. The move positions SKAN as a comprehensive solution provider in the pharmaceutical value chain, promising immediate value contribution and strengthening its industry positioning.
The most recent analyst rating on (CH:SKAN) stock is a Buy with a CHF92.00 price target. To see the full list of analyst forecasts on SKAN Group AG stock, see the CH:SKAN Stock Forecast page.
More about SKAN Group AG
SKAN Group AG is a leader in aseptic and aseptic-toxic manufacturing processes for the pharmaceutical and biotech industries. The company specializes in high-quality isolator systems for drug filling under strict sterility standards and offers process support, services, and consumables. Founded in 1968, SKAN employs around 1,500 people globally, with its headquarters in Allschwil, Switzerland.
Average Trading Volume: 17,115
Technical Sentiment Signal: Buy
Current Market Cap: CHF1.68B
See more data about SKAN stock on TipRanks’ Stock Analysis page.